GL Capital to acquire HutchMed’s OTC venture

26 March 2021 - Deborah Wilkes

Premium

Private-equity firm GL Capital is acquiring Hutchison China MediTech’s (HutchMed’s) holding in its non-core OTC joint venture Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company (HBYS).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: